annual accounts payable:
$18.00M+$1.00M(+5.88%)Summary
- As of today (September 16, 2025), RCUS annual accounts payable is $18.00 million, with the most recent change of +$1.00 million (+5.88%) on December 31, 2024.
- During the last 3 years, RCUS annual accounts payable has risen by +$8.00 million (+80.00%).
- RCUS annual accounts payable is now -10.00% below its all-time high of $20.00 million, reached on December 31, 2022.
Performance
RCUS Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$29.00M+$7.00M(+31.82%)Summary
- As of today (September 16, 2025), RCUS quarterly accounts payable is $29.00 million, with the most recent change of +$7.00 million (+31.82%) on June 30, 2025.
- Over the past year, RCUS quarterly accounts payable has increased by +$14.00 million (+93.33%).
- RCUS quarterly accounts payable is now at all-time high.
Performance
RCUS quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RCUS Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.9% | +93.3% |
| 3 y3 years | +80.0% | +31.9% |
| 5 y5 years | +282.6% | +140.6% |
RCUS Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -10.0% | +80.0% | at high | +175.0% |
| 5 y | 5-year | -10.0% | +282.6% | at high | +257.9% |
| alltime | all time | -10.0% | +480.3% | at high | +1275.1% |
RCUS Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $29.00M(+31.8%) |
| Mar 2025 | - | $22.00M(+22.2%) |
| Dec 2024 | $18.00M(+5.9%) | $18.00M(+38.5%) |
| Sep 2024 | - | $13.00M(-13.3%) |
| Jun 2024 | - | $15.00M(-6.3%) |
| Mar 2024 | - | $16.00M(-5.9%) |
| Dec 2023 | $17.00M(-15.0%) | $17.00M(0.0%) |
| Sep 2023 | - | $17.00M(+41.7%) |
| Jun 2023 | - | $12.00M(-57.1%) |
| Mar 2023 | - | $28.00M(+40.0%) |
| Dec 2022 | $20.00M(+100.0%) | $20.00M(+89.6%) |
| Sep 2022 | - | $10.55M(-52.0%) |
| Jun 2022 | - | $21.98M(+21.5%) |
| Mar 2022 | - | $18.09M(+76.3%) |
| Dec 2021 | $10.00M | $10.26M(-22.4%) |
| Sep 2021 | - | $13.22M(-22.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $16.96M(-30.9%) |
| Mar 2021 | - | $24.54M(+56.5%) |
| Dec 2020 | $15.68M(+233.4%) | $15.68M(+93.6%) |
| Sep 2020 | - | $8.10M(-32.8%) |
| Jun 2020 | - | $12.05M(+396.8%) |
| Mar 2020 | - | $2.43M(-48.4%) |
| Dec 2019 | $4.70M(+51.6%) | $4.70M(+61.9%) |
| Sep 2019 | - | $2.90M(+18.7%) |
| Jun 2019 | - | $2.45M(-13.5%) |
| Mar 2019 | - | $2.83M(-8.8%) |
| Dec 2018 | $3.10M(-18.8%) | $3.10M(+47.1%) |
| Sep 2018 | - | $2.11M(-60.9%) |
| Jun 2018 | - | $5.39M(+37.4%) |
| Mar 2018 | - | $3.92M(+2.6%) |
| Dec 2017 | $3.82M(-1.2%) | $3.82M |
| Dec 2016 | $3.87M | - |
FAQ
- What is Arcus Biosciences, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. annual accounts payable year-on-year change?
- What is Arcus Biosciences, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. quarterly accounts payable year-on-year change?
What is Arcus Biosciences, Inc. annual accounts payable?
The current annual accounts payable of RCUS is $18.00M
What is the all time high annual accounts payable for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high annual accounts payable is $20.00M
What is Arcus Biosciences, Inc. annual accounts payable year-on-year change?
Over the past year, RCUS annual accounts payable has changed by +$1.00M (+5.88%)
What is Arcus Biosciences, Inc. quarterly accounts payable?
The current quarterly accounts payable of RCUS is $29.00M
What is the all time high quarterly accounts payable for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high quarterly accounts payable is $29.00M
What is Arcus Biosciences, Inc. quarterly accounts payable year-on-year change?
Over the past year, RCUS quarterly accounts payable has changed by +$14.00M (+93.33%)